China First Domestic COVID-19 Antibody Therapy Moves Towards Green Light

Strong Overseas Efficacy Data

 
• By Brian Yang
  
CHINA PUBLIC HEALTH FIGURE ZHONG NANSHAN (FOURTH FORM LEFT) LEADS BRII PHASE II STUDY IN CHINA • Source: Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia